The Week in Review provides an overview of the past week’s top health care content, including industry news and trends, Mayo Clinic and Mayo Clinic Laboratories news, and upcoming events.
With attention to mpox fading, health officials fear infections will go undetected and unreported
Dwindling case counts obscure an important reality: The global footprint of mpox, which until a few years ago could only be contracted in parts of Africa, has expanded substantially. Source: STAT
As COVID surges in China, US begins testing more travelers
As of Thursday, the CDC is also requiring travelers to the U.S. from China, Hong Kong and Macao to take a COVID-19 test no more than two days before travel and provide a negative result before boarding a flight. Source: AP
FDA approves Alzheimer's drug that appears to modestly slow disease
An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%. Source: NPR